Helix BioMedix HXBM Stock
Helix BioMedix Price Chart
Helix BioMedix HXBM Financial and Trading Overview
| Helix BioMedix stock price | 7.19 USD |
| Previous Close | 23 USD |
| Open | 23.1 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 23 - 23 USD |
| 52 Week Range | 12.21 - 26 USD |
| Volume | 200 USD |
| Avg. Volume | 6 USD |
| Market Cap | 5.8M USD |
| Beta (5Y Monthly) | 0.337323 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.6 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HXBM Valuation Measures
| Enterprise Value | 3.6M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.8075182 |
| Price/Book (mrq) | 3.3145986 |
| Enterprise Value/Revenue | 1.74 |
| Enterprise Value/EBITDA | -1.544 |
Trading Information
Helix BioMedix Stock Price History
| Beta (5Y Monthly) | 0.337323 |
| 52-Week Change | 88.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26 USD |
| 52 Week Low | 12.21 USD |
| 50-Day Moving Average | 23.12 USD |
| 200-Day Moving Average | 23.19 USD |
HXBM Share Statistics
| Avg. Volume (3 month) | 6 USD |
| Avg. Daily Volume (10-Days) | 20 USD |
| Shares Outstanding | 165.72K |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:300 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2011 |
| Most Recent Quarter (mrq) | September 30, 2012 |
| Next Fiscal Year End | December 31, 2012 |
Profitability
| Profit Margin | -125.062% |
| Operating Margin (ttm) | -117.30% |
| Gross Margin | 68.96% |
| EBITDA Margin | -112.72% |
Management Effectiveness
| Return on Assets (ttm) | -58.99% |
| Return on Equity (ttm) | -122.53% |
Income Statement
| Revenue (ttm) | 2.07M USD |
| Revenue Per Share (ttm) | 12.47 USD |
| Quarterly Revenue Growth (yoy) | 18.80% |
| Gross Profit (ttm) | 1.16M USD |
| EBITDA | -2328767 USD |
| Net Income Avi to Common (ttm) | -2583671 USD |
| Diluted EPS (ttm) | -12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 216.53K USD |
| Total Cash Per Share (mrq) | 1.31 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.329 |
| Book Value Per Share (mrq) | 6.939 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1818997 USD |
| Levered Free Cash Flow (ttm) | -1083466 USD |
Profile of Helix BioMedix
| Country | United States |
| State | WA |
| City | Bothell |
| Address | 22121-17th Avenue SE |
| ZIP | 98021 |
| Phone | 425-402-8400 |
| Website | https://www.helixbiomedix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.
Q&A For Helix BioMedix Stock
What is a current HXBM stock price?
Helix BioMedix HXBM stock price today per share is 7.19 USD.
How to purchase Helix BioMedix stock?
You can buy HXBM shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Helix BioMedix?
The stock symbol or ticker of Helix BioMedix is HXBM.
Which industry does the Helix BioMedix company belong to?
The Helix BioMedix industry is Biotechnology.
How many shares does Helix BioMedix have in circulation?
The max supply of Helix BioMedix shares is 224.71K.
What is Helix BioMedix Price to Earnings Ratio (PE Ratio)?
Helix BioMedix PE Ratio is now.
What was Helix BioMedix earnings per share over the trailing 12 months (TTM)?
Helix BioMedix EPS is -3.6 USD over the trailing 12 months.
Which sector does the Helix BioMedix company belong to?
The Helix BioMedix sector is Healthcare.